Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.
Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes – Biotech Investments
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes 19.12.2023 /